Ryan McNeil1,2, Thomas Kerr1,3, Bernie Pauly4,5, Evan Wood1,3, Will Small1,2. 1. BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada. 2. Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada. 3. Department of Medicine, University of British Columbia, Vancouver, BC, Canada. 4. School of Nursing, University of Victoria, Victoria, BC, Canada. 5. Centre for Addictions Research of British Columbia, Victoria, BC, Canada.
Abstract
AIMS: To explore the perspectives of structurally vulnerable people who use drugs (PWUD) regarding: (1) the potential integration of harm reduction interventions (e.g. supervised drug consumption services, opioid-assisted treatment) into hospitals; and (2) the implications of these interventions for patient-centered care, hospital outcomes and drug-related risks and harms. DESIGN: Semi-structured qualitative interviews. SETTING: Vancouver, Canada. PARTICIPANTS: Thirty structurally vulnerable PWUD who had been discharged from hospital against medical advice within the past 2 years, and hospitalized multiple times over the past 5 years. MEASUREMENTS: Semi-structured interview guide including questions to elicit perspectives on hospital-based harm reduction interventions. FINDINGS: Participant accounts highlighted that hospital-based harm reduction interventions would promote patient-centered care by: (1) prioritizing hospital care access and risk reduction over the enforcement of abstinence-based drug policies; (2) increasing responsiveness to subjective health needs (e.g. pain and withdrawal symptoms); and (3) fostering 'culturally safe' care. CONCLUSIONS: Hospital-based harm reduction interventions for people who use drugs, such as supervised drug consumption services and opioid-assisted treatment, can potentially improve hospital care retention, promote patient-centered care and reduce adverse health outcomes among people who use drugs.
AIMS: To explore the perspectives of structurally vulnerable people who use drugs (PWUD) regarding: (1) the potential integration of harm reduction interventions (e.g. supervised drug consumption services, opioid-assisted treatment) into hospitals; and (2) the implications of these interventions for patient-centered care, hospital outcomes and drug-related risks and harms. DESIGN: Semi-structured qualitative interviews. SETTING: Vancouver, Canada. PARTICIPANTS: Thirty structurally vulnerable PWUD who had been discharged from hospital against medical advice within the past 2 years, and hospitalized multiple times over the past 5 years. MEASUREMENTS: Semi-structured interview guide including questions to elicit perspectives on hospital-based harm reduction interventions. FINDINGS:Participant accounts highlighted that hospital-based harm reduction interventions would promote patient-centered care by: (1) prioritizing hospital care access and risk reduction over the enforcement of abstinence-based drug policies; (2) increasing responsiveness to subjective health needs (e.g. pain and withdrawal symptoms); and (3) fostering 'culturally safe' care. CONCLUSIONS: Hospital-based harm reduction interventions for people who use drugs, such as supervised drug consumption services and opioid-assisted treatment, can potentially improve hospital care retention, promote patient-centered care and reduce adverse health outcomes among people who use drugs.
Authors: Joseph O Merrill; Lorna A Rhodes; Richard A Deyo; G Alan Marlatt; Katharine A Bradley Journal: J Gen Intern Med Date: 2002-05 Impact factor: 5.128
Authors: Kevin J P Craib; Patricia M Spittal; Evan Wood; Nancy Laliberte; Robert S Hogg; Kathy Li; Katherine Heath; Mark W Tyndall; Michael V O'Shaughnessy; Martin T Schechter Journal: CMAJ Date: 2003-01-07 Impact factor: 8.262
Authors: Aslam H Anis; Huiying Sun; Daphne P Guh; Anita Palepu; Martin T Schechter; Michael V O'Shaughnessy Journal: CMAJ Date: 2002-09-17 Impact factor: 8.262
Authors: Joanne Neale; Caral Brown; Aimee N C Campbell; Jermaine D Jones; Verena E Metz; John Strang; Sandra D Comer Journal: Addiction Date: 2018-12-28 Impact factor: 6.526
Authors: Michael C Otterstatter; Alexis Crabtree; Sabina Dobrer; Brooke Kinniburgh; Salman Klar; Anthony Leamon; Jennifer May-Hadford; Christopher Mill; Mina Park; Andrew W Tu; Lu Zheng Journal: Health Promot Chronic Dis Prev Can Date: 2018-09 Impact factor: 3.240
Authors: Taylor Fleming; Alexandra B Collins; Geoff Bardwell; Al Fowler; Jade Boyd; M J Milloy; Will Small; Ryan McNeil Journal: PLoS One Date: 2021-02-26 Impact factor: 3.240